GRAIL, Inc.

Status: Publicly traded

Direct answer

GRAIL, Inc. is publicly traded on NASDAQ under the ticker GRAL.

GRAIL, Inc. is a biotechnology firm dedicated to advancing innovations for detecting cancer at its earliest stages. Among its key offerings is Galleri, a screening test designed for individuals aged 50 and above who show no symptoms of the disease. GRAIL also offers DAC (Diagnostic Aid for Cancer), which assists in expediting the diagnostic process for patients where cancer is clinically suspected. Additionally, the...

Can you invest in GRAIL, Inc.?

Yes. GRAIL, Inc. is publicly traded on NASDAQ under the ticker GRAL.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for GRAIL, Inc.

Detailed equity research is provided by MarketSnap.